Advertisement
Screener

NEURAXIS, INC. (NRXS) Shareholder Equity

NEURAXIS, INC. (NRXS) Shareholder Equity

  • 2026-06-30: Preferred Stock, Value, IssuedUSD $3.80K; Common Stock, Value, IssuedUSD $12.47K; Additional Paid in CapitalUSD $76.38M; Retained Earnings (Accumulated Deficit)USD $-69.66M.
  • 2026-03-31: Preferred Stock, Value, IssuedUSD $3.80K; Common Stock, Value, IssuedUSD $11.45K; Additional Paid in CapitalUSD $72.09M; Retained Earnings (Accumulated Deficit)USD $-66.36M.
  • 2025-12-31: Preferred Stock, Value, IssuedUSD $3.80K; Common Stock, Value, IssuedUSD $10.65K; Additional Paid in CapitalUSD $67.99M; Retained Earnings (Accumulated Deficit)USD $-64.60M.
  • 2025-09-30: Preferred Stock, Value, IssuedUSD $3.90K; Common Stock, Value, IssuedUSD $9.89K; Additional Paid in CapitalUSD $65.16M; Retained Earnings (Accumulated Deficit)USD $-62.89M.

NEURAXIS, INC. Shareholder Equity

Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.

Period endPreferred Stock, Value, Issued
USD
Common Stock, Value, Issued
USD
Additional Paid in Capital
USD
Retained Earnings (Accumulated Deficit)
USD
Stockholders' Equity Attributable to Parent
USD
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs
USD
APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
USD
APIC, Share-based Payment Arrangement, Increase for Cost Recognition
USD
Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature
USD
Adjustments to Additional Paid in Capital, Warrant Issued
USD
2026-06-30$3.80K$12.47K$76.38M$-69.66M$6.74M3 month · $66.13K(m)3 month · $639.80K(m)(m)
2026-03-31$3.80K$11.45K$72.09M$-66.36M$5.75M3 month · $110.43K(m)3 month · $329.43K(m)(m)
2025-12-31$3.80K$10.65K$67.99M$-64.60M$3.40M12 month · $688.80K12 month · $251.11K12 month · $596.85K(m)(m)
2025-09-30$3.90K$9.89K$65.16M$-62.89M$2.28M3 month · $40.34K3 month · $160.87K(m)(m)(m)
2025-06-30$3.90K$9.86K$65.01M$-60.77M$4.25M3 month · $490.80K3 month · $173.04K3 month · $173.04K(m)(m)
2025-03-31$4.28K$7.22K$59.33M$-59.08M$258.48K(m)3 month · $251.11K3 month · $105.81K(m)(m)
2024-12-31$4.28K$6.99K$58.86M$-56.80M$2.07M(m)(m)(m)12 month · $-165.58K12 month · $157.75K
2024-09-30(m)$6.98K$53.55M$-55.35M$-1.79M(m)(m)(m)3 month · $-165.58K3 month · $65.43K
2024-06-30(m)$6.84K$48.33M$-53.60M$-5.26M(m)(m)(m)(m)3 month · $44.85K
2024-03-31(m)$6.59K$47.49M$-50.68M$-3.18M(m)(m)(m)(m)3 month · $15.54K
2023-12-31(m)$6.51K$47.15M$-48.56M$-1.40M(m)(m)(m)(m)12 month · $3.72M
2023-09-30(m)$5.15K$45.90M$-46.97M$-1.06M(m)(m)(m)(m)(m)
2023-06-30(m)$1.96K$28.36M$-38.34M$-9.98M(m)(m)(m)(m)(m)
2023-03-31(m)(m)(m)(m)$-7.75M(m)(m)(m)(m)(m)
2022-12-31(m)$1.96K$28.36M$-33.93M$-5.57M(m)(m)12 month · $27.32K(m)(m)
2022-09-30(m)(m)(m)(m)$-5.56M(m)(m)3 month · $3.20K(m)(m)
2022-06-30(m)(m)(m)(m)$-3.49M(m)(m)3 month · $12.13K(m)(m)
2022-03-31(m)(m)(m)(m)$-1.98M(m)(m)3 month · $11.99K(m)(m)
2021-12-31(m)(m)(m)(m)$-825.66K(m)(m)(m)(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Nexalin Technology, Inc. (NXL)United States$0.094B
electroCore, Inc. (ECOR)United States$0.102B
Streamex Corp. (STEX)United States$0.089B-0.19
Vivani Medical, Inc. (VANI)United States$0.111B
Stereotaxis, Inc. (STXS)United States$0.130B-7.53
Outset Medical, Inc. (OM)United States$0.059B-1.09
PRECISION OPTICS CORPORATION, INC. (POCI)United States$0.052B
QT IMAGING HOLDINGS, INC. (QTI)United States$0.037B
EDAP TMS SA (FOCL)$0.171B
IRIDEX CORP (IRIX)United States$0.011B